Latest News

Youth-led campaigns: fresh ways of communicating about public health issues

Youth-led campaigns have been instrumental in finding fresh and innovative ways to communicate about public health issues. These campaigns have the ability to make complex…

Paving the way towards coordinated clinical trials in public health emergencies in the EU

The European Medicines Agency (EMA) has released a workshop report outlining recommendations to enhance clinical trials during public health emergencies in the EU. The report…

Direct Healthcare Professional Communication (DHPC) on Voxzogo® (vosoritide): change to administration syringe and needle leading to product administration in Units (U) instead of mL

The Federal Institute for Drugs and Medical Devices (BfArM) has released important information regarding the pharmacovigilance of Voxzogo® (vosoritide). The latest update pertains to a…

Use of real-world evidence in regulatory decision making – EMA publishes review of its studies

The European Medicines Agency (EMA) has released a review highlighting the use of real-world evidence (RWE) in regulatory decision-making. Real-world evidence refers to data collected…

June 23, 2023

Phasing out of extraordinary COVID-19 regulatory flexibilities

The European Medicines Agency (EMA) has officially declared the gradual discontinuation of exceptional regulatory flexibilities that were put in place during the COVID-19 pandemic. These…

July 6, 2023

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC)

The European Medicines Agency (EMA) recently issued an essay outlining the main points of the Pharmacovigilance Risk Assessment Committee (PRAC) conference, which took place from…

July 7, 2023

EMA statement on ongoing review of GLP-1 receptor agonists

In response to an ongoing review, the European Medicines Agency (EMA) has issued a statement regarding GLP-1 receptor agonists. These medications are commonly used in…

July 11, 2023

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP)

The Committee for Veterinary Medicinal Products (CVMP) recently finished its conference, which focused on enhancing animal health and welfare from July 11 to 13, 2023.…

July 14, 2023

Get In Touch

We value your input and always appreciate feedback. Your suggestions and comments help us improve our services, ensuring that we consistently meet your needs and exceed your expectations.

	MO - FR 9:00 am - 5:00 pm
	+ 420 774 557 550
	[email protected]
	Czech Republic, Nile House, Karolinská 654/2, Karlín, 186 00, Prague